RxDoctor Payments Data

Victoria Statler

Pediatric Infectious Diseases · Louisville, KYNPI 1770604191

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Seqirus USA Inc at 57.5% of the total. Reporting peaked in 2021 at $5,500 and has fallen 77.4% since, to $1,242 in 2025.

$16,166in general payments, 2019–2025

Across 24 payments — averaging $673.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Seqirus USA Inc$9K
  • Pfizer$2K
  • Sanofi Pasteur Inc.$2K
  • Astellas Pharma US Inc$1K
  • Merck$1K
$390,664in research payments, 2019–2025

Across 167 payments — averaging $2339.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$148K
  • Sanofi Pasteur Inc.$132K
  • Gilead$49K
  • Astellas Pharma Global Development$34K
  • Astellas US Technologies$23K
  • Pfizer$6K

What the payments were for

  • Consulting fees$5,20832%
  • Speaking & faculty fees$9,03856%
  • Travel & lodging$1,2918%
  • Food & beverage$6304%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Seqirus USA Inc4$9,300
Pfizer5$2,450
Sanofi Pasteur Inc.2$1,724
Astellas Pharma US Inc3$1,451
Merck10$1,242

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric infectious diseases providers in Kentuckyto place this figure against a meaningful peer group, so we don't.

Other pediatric infectious diseases in Louisville

Where these figures come from

Is this you, or does something look wrong? →